• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Epitope specificity, antibody-dependent cellular cytotoxicity, and neutralizing activity of antibodies to human immunodeficiency virus type 1 in autoimmune MRL/lpr mice.

作者信息

Lombardi V, Placido R, Scarlatti G, Romiti M L, Mattei M, Mariani F, Poccia F, Rossi P, Colizzi V

机构信息

Department of Pediatrics, University of Rome Ter Vergata, Italy.

出版信息

J Infect Dis. 1993 Jun;167(6):1267-73. doi: 10.1093/infdis/167.6.1267.

DOI:10.1093/infdis/167.6.1267
PMID:7684755
Abstract

The specificity and functional activity of antibodies to human immunodeficiency virus (HIV) in the sera of MRL/lpr mice were analyzed by peptide-ELISA, antibody-dependent cellular cytotoxicity, and virus neutralization. The specificity of the antibodies in the sera of autoimmune MRL/lpr mice was similar to that of HIV-infected persons; the mouse sera specifically recognized the V3 loop of gp120 and immunodominant regions of gp41 and p24. Moreover, such binding was inhibited both by human HIV-positive sera and by soluble peptides in competition experiments. MRL/lpr sera displayed anti-HIV antibody-dependent cellular cytotoxicity using human peripheral blood lymphocytes as effector cells and HIV-infected H9 cells. Furthermore, the fact that MRL/lpr sera neutralized in vitro infectious HIV (both strains IIIB and MN) suggests these antibodies recognize viral epitopes on the membrane of infected T cells.

摘要

相似文献

1
Epitope specificity, antibody-dependent cellular cytotoxicity, and neutralizing activity of antibodies to human immunodeficiency virus type 1 in autoimmune MRL/lpr mice.
J Infect Dis. 1993 Jun;167(6):1267-73. doi: 10.1093/infdis/167.6.1267.
2
Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120.针对gp120保守肽决定簇的抗体的载体依赖性特异性
Vaccine. 2003 Mar 7;21(11-12):1213-8. doi: 10.1016/s0264-410x(02)00504-2.
3
Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases.人类和小鼠自身免疫性疾病中抗HIV抗体的表位特异性
AIDS Res Hum Retroviruses. 1996 Apr 10;12(6):491-6. doi: 10.1089/aid.1996.12.491.
4
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.一项关于具有天然和嵌合序列的合成HIV-1肽与津巴布韦、坦桑尼亚和瑞典HIV-1阳性血清反应性差异的调查。
AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002.
5
Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.1型人类免疫缺陷病毒包膜内V3环环境的改变增强了中和作用。
J Virol. 1994 Jun;68(6):3459-66. doi: 10.1128/JVI.68.6.3459-3466.1994.
6
Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.用在植物病毒表面表达的gp41的22个氨基酸肽免疫的三株小鼠中,对1型人类免疫缺陷病毒中和抗体的刺激作用。
Vaccine. 1996 Jun;14(8):799-810. doi: 10.1016/0264-410x(95)00229-t.
7
Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.乌干达抗血清与人免疫缺陷病毒1型V3环表位编码肽的反应
AIDS Res Hum Retroviruses. 1994 May;10(5):577-83. doi: 10.1089/aid.1994.10.577.
8
Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.一种单克隆抗独特型抗体对HIV-1中和单克隆抗体110.3和110.4以及gp120的V3环的双重特异性。
Virology. 1994 Dec;205(2):554-7. doi: 10.1006/viro.1994.1678.
9
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.用来自gp120第三可变区的合成肽产生的1型人类免疫缺陷病毒特异性单克隆抗体和组特异性多克隆中和抗体。
J Virol. 1992 Mar;66(3):1823-31. doi: 10.1128/JVI.66.3.1823-1831.1992.
10
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.能够呈现HIV-1 V3环冠部且构象适合产生447-52D样抗体的免疫原的设计。
Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588.

引用本文的文献

1
Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host.中枢耐受决定天然宿主中针对持续性病毒的中和性 B 细胞库。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2318657121. doi: 10.1073/pnas.2318657121. Epub 2024 Mar 6.
2
HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.HIV-1 包膜并不能在实验性自身免疫性脑脊髓炎小鼠模型中诱导产生保护性广谱中和抗体。
Front Immunol. 2021 Nov 2;12:771359. doi: 10.3389/fimmu.2021.771359. eCollection 2021.
3
Immunological tolerance as a barrier to protective HIV humoral immunity.
免疫耐受作为保护性 HIV 体液免疫的障碍。
Curr Opin Immunol. 2017 Aug;47:26-34. doi: 10.1016/j.coi.2017.06.004. Epub 2017 Jul 17.
4
Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies.突破外周耐受可促进HIV-1中和抗体的产生。
J Exp Med. 2017 Aug 7;214(8):2283-2302. doi: 10.1084/jem.20161190. Epub 2017 Jul 11.